A comprehensive review of the progress of cell migration inducing hyaluronidase 1. Issue 47 (25th November 2022)

• Record Type: Journal Article
• Authors: Miao, Xiangguang; Wang, Yukai; Miao, Zhiguo; Pan, Haili
• Is Part Of: Medicine. Volume 101:Issue 47(2022)
• Page Start: e31610
• Publication Date: 2022-11-25
• Subjects: CEMIP (cell migration-inducing hyaluronidase 1) -- hyaluronidase 1 -- KIAA1199 -- tumor -- migration -- tumorigenesis; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000031610
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : The gene cell migration inducing hyaluronidase 1 (CEMIP) is on chromosome 15q25 and codes for a 150-kDa protein with an N-terminal secretion signal, a G8 domain, 2 GG domains, and several repeats. It was first described as a specific protein in the inner ear relating to nonsyndromic hearing loss. Recently, increasing research detected its association in various cancers, determining the progression, metastasis, and prognosis by influencing the proliferation and invasion of the cells. This relation is accomplished through various interacting pathways, such as the Wnt/β-catenin signaling pathway and the epidermal growth factor receptor signaling pathway. Thus, CEMIP could be a novel and potential focus for tumor diagnosis and treatment, but further studies on the regulatory role of CEMIP in vivo and in vitro are still needed. Herein, we summarize the process in recent studies of CEMIP, especially in cancer research.